These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3696857)

  • 1. [Clinico-bacteriological evaluation of the effectiveness of amikacin in chronic bronchopulmonary diseases and mucoviscidosis in children].
    Volkov IK; Katosova LK; Skala LZ; Sotnikova GD; Nekhorosheva AG
    Pediatriia; 1987; (10):37-40. PubMed ID: 3696857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
    Semykin SIu; Postnikov SS; Polikarpova SV; Perederko LV
    Antibiot Khimioter; 2003; 48(12):18-21. PubMed ID: 15176099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and bacteriological study on the use of carbenicillin in the bronchopulmonary infections of mucoviscidosis].
    Mastella G; Bonomi U; Piacentini I; Mengoli C
    Minerva Pediatr; 1971 Oct; 23(41):1721-31. PubMed ID: 5133185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and bacteriological efficacy and tolerability of meropenem in the treatment of bronchopulmonary affections in children with mucoviscidosis].
    Semykin SIu; Postnikov SS; Perederko LV; Polikarpova SV; Dubovik LG
    Antibiot Khimioter; 2006; 51(7):28-33. PubMed ID: 18035731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].
    Gilly R; Fougerat J
    Poumon Coeur; 1974; 30(5):375-82. PubMed ID: 4469905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G; Gagliardini R; Rocchi AL; Palumbo P
    Minerva Pediatr; 1986 Jul; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract]   [Full Text] [Related]  

  • 8. [Etiology of the inflammatory process in chronic pneumonia and mucoviscidosis in children].
    Rachinskiĭ SV; Katosova LK; Sattorov GN; Shabalova LA
    Pediatriia; 1984 Jan; (1):28-32. PubMed ID: 6424089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of anaerobic flora in development of bronchopulmonary infection in children with mucoviscidosis].
    Semykin SIu; Postnikov SS; Osipov GA
    Antibiot Khimioter; 2009; 54(3-4):26-8. PubMed ID: 19711846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Amikacin in the treatment of infectious-inflammatory diseases in patients at a therapeutic hospital].
    Sokolova VI; Kuznetsova SM; Kamnev IuV
    Antibiot Khimioter; 1990 May; 35(5):36-9. PubMed ID: 2383154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucoviscidosis and chronic nonspecific pneumonia in children].
    Gorodetskaia EG; Gudzenko ZhP
    Pediatriia; 1967 Dec; 46(12):24-8. PubMed ID: 5610663
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and laboratory evaluation of amikacin].
    Borowski J; Musierowicz A; Dzierzanowska D; Niedźwiecka M; Gruszecki W
    Pol Tyg Lek; 1979 Oct; 34(44):1721-5. PubMed ID: 514892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bacteriological findings in selected inflammatory bronchopulmonary diseases].
    Dürschmied H; Knöll P; Wilde J
    Z Erkr Atmungsorgane; 1986; 167(1-2):68-73. PubMed ID: 3532586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of disorders of hemostasis in children with chronic pneumonia and mucoviscidosis].
    Niiazova MKh; Kapranov NI; Makatsariia AD
    Pediatriia; 1989; (2):27-30. PubMed ID: 2726362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology of the infectious process in pulmonary and mixed forms of mucoviscidosis in children].
    Vishniakova LA; Zhelenina LA; Marzavina OV; Gembitskaia TE; Orlov AV; Drinevskiĭ VP
    Vestn Ross Akad Med Nauk; 1995; (9):57-60. PubMed ID: 7580418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of therapeutic and rehabilitation complexes in the treatment of children with chronic bronchopulmonary diseases and mucoviscidosis].
    Simonova OI; Savel'ev BP; Markov BA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1988; (3):23-5. PubMed ID: 3212958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers].
    Wencel J; Czaplicki M; Borkowski A; Malewski AW
    Pol Tyg Lek; 1978 Dec; 33(50):1937-8. PubMed ID: 733620
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amikacin in the child: efficacy, tolerance, effects on the intestinal microbial ecosystem].
    Mathieu H; Lambert-Zechovsky N; Beaufils F; Blum C; Binger E; Guillot M
    Nouv Presse Med; 1979 Oct; 8(42):3482-91. PubMed ID: 537901
    [No Abstract]   [Full Text] [Related]  

  • 19. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Lau WK; Young LS; Osher AB; Dooley RR
    Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.